Today's biggest winners and losers in the stock market, a look at the notable movers:

On this episode of Stock Movers:
-JM Smucker (SJM) shares rise 4.8% ahead of the bell after organic sales and adjusted EPS beat expectations for the fourth quarter. The midpoint of the initial fiscal 2027 adjusted EPS range forecast is above consensus. In prepared remarks, the company said it expects the board to maintain the current dividend policy, which is to return approximately 40% to 45% of its annual adjusted earnings per share to shareholders, reflecting dividend growth consistent with future earnings.

-SailPoint (SAIL) shares are down 13% in premarket trading, after the software company reported its first-quarter results and gave an outlook. The report showed stronger-than-expected revenue, and the full-year forecast was raised on key metrics, but it may not have been robust enough to extend recent strength in the stock, which is up nearly 70% off an April low, as of last close.

- Shares of Nuvalent (NUVL) rose sharply in pre-market trading after GSK agreed to acquire the company in a deal valued at $10.6 billion (7.9 billion pounds). GSK will pay $124 per share in cash, a 40% premium over Nuvalent's closing share price on Monday. Nuvalent (NUVL) is up 39%

Today's biggest winners and losers in the stock market, a look at the notable movers: On this episode of Stock Movers: -JM Smucker (SJM) shares rise 4.8% ahead of the bell after organic sales and adjusted EPS beat expectations for the fourth quarter. The midpoint of the initial fiscal 2027 adjusted EPS range forecast is above consensus. In prepared remarks, the company said it expects the board to maintain the current dividend policy, which is to return approximately 40% to 45% of its annual adjusted earnings per share to shareholders, reflecting dividend growth consistent with future earnings. -SailPoint (SAIL) shares are down 13% in premarket trading, after the software company reported its first-quarter results and gave an outlook. The report showed stronger-than-expected revenue, and the full-year forecast was raised on key metrics, but it may not have been robust enough to extend recent strength in the stock, which is up nearly 70% off an April low, as of last close. - Shares of Nuvalent (NUVL) rose sharply in pre-market trading after GSK agreed to acquire the company in a deal valued at $10.6 billion (7.9 billion pounds). GSK will pay $124 per share in cash, a 40% premium over Nuvalent's closing share price on Monday. Nuvalent (NUVL) is up 39%

Listen for five-minute conversations on today's biggest winners and losers in the stock market. 

Subscribe for analysis on the companies making news in global equity markets. Episodes are published throughout the day to track stock moves from New York, London, Frankfurt and Paris. Join us for investment news covering technology, energy, finance, health care, communications, industrials, utilities, consumer staples, materials, real estate and more.

Listen for five-minute conversations on today's biggest winners and losers in the stock market.&nbsp;
Subscribe for analysis on the companies making news in global equity markets. Episodes are published throughout the day to track stock moves from New York, London, Frankfurt and Paris. Join us for investment news covering technology, energy, finance, health care, communications, industrials, utilities, consumer staples, materials, real estate and more.

Listen for news on today's biggest winners and losers in the stock market.

Stock Movers

JM Smucker Rises, SailPoint Slides, Nuvalent Jumps on GSK Deal

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/edd46bad-2bca-4bab-bece-b464013a6813/transcript